Tuesday, October 14, 2025, 2:00 pm EDT
The neural mechanisms involved in suicide remain poorly understood. This webinar will discuss a series of studies investigating the biological factors underlying suicide risk, with a particular focus on the suicide crisis. Dr. Lamontagne will show preliminary effects of ketamine treatment on outcomes. The data incorporate magnetoencephalography (MEG), clinical assessments, and biological assays to provide a comprehensive understanding of suicide and inform future directions for prevention.
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Sign up for other upcoming webinars.
View past webinar recordings.
Presented by
Postdoctoral Fellow, Experimental Therapeutics and Pathophysiology Branch
National Institute of Mental Health (NIMH)
2023 Young Investigator Grant
Dr. Lamontagne is a postdoctoral fellow in the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health (NIMH). He examines the electrophysiological correlates of suicide with a focus on understanding how ketamine modulates suicide-related pathophysiology. His background in neuroscience research ranges from preclinical animal models to human clinical trials. Broadly, his training centers on elucidating the effects of stress on various biomarkers of mood disorders. Most of his works involve pharmacological challenges to remediate stress-induced perturbations, thus exploring potential targets for novel biological treatments.
Moderated by
Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
